Testing effectiveness (Phase 2)Ended earlyNCT01453595What this trial is testingBEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)Who this might be right forRenal Cancer Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Active Not RecruitingNCT05653882What this trial is testingA Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid TumorsWho this might be right forSolid TumorNon Small Cell Lung CancerMelanoma+2 more Asher Biotherapeutics, Inc. 552
Testing effectiveness (Phase 2)Study completedNCT00848640What this trial is testingStudy of Sorafenib in Patients With Advanced Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Egyptian Foundation For Cancer Research 75
Early research (Phase 1)Study completedNCT00623064What this trial is testingLapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter European Organisation for Research and Treatment of Cancer - EORTC 18
Early research (Phase 1)Ended earlyNCT06630247What this trial is testingA Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid CancersSolid Tumor CancerSolid Tumor Malignancy+4 more Exelixis 9
Testing effectiveness (Phase 2)Study completedNCT02535533What this trial is testingSLM + Axitinib for Clear Cell RCCWho this might be right forAdvanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) Mohammed Milhem 45
Testing effectiveness (Phase 2)Looking for participantsNCT06750185What this trial is testingSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor BioNTech SE 248
Testing effectiveness (Phase 2)Active Not RecruitingNCT04022343What this trial is testingNeoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRenal Cell CarcinomaStage III Renal Cell Cancer AJCC v8 Emory University 22
Not applicableStudy completedNCT04033991What this trial is testingStudy of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.Who this might be right forCarcinomaRenal Cell Pfizer 684
Testing effectiveness (Phase 2)Study completedNCT00354250What this trial is testingIspinesib in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forRecurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT03170960What this trial is testingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forUrothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more Exelixis 914
Testing effectiveness (Phase 2)Study completedNCT04339062What this trial is testingCemiplimab in AlloSCT/SOT Recipients With CSCCWho this might be right forCutaneous Squamous Cell CarcinomaAdvanced Cancer Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)UnknownNCT01118039What this trial is testingSunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Hospital del Mar 41
Large-scale testing (Phase 3)WithdrawnNCT03693573What this trial is testingAtezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT00420888What this trial is testingABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Active Biotech AB 526
Early research (Phase 1)WithdrawnNCT01441388What this trial is testingCrizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.Who this might be right forCarcinoma, Renal CellGlioblastomaCarcinoma, Hepatocellular Pfizer
Testing effectiveness (Phase 2)Study completedNCT01743469What this trial is testingA Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric CancersWho this might be right forAdvanced or Metastatic Hepatocellular CancerAdvanced or Metastatic Ovarian CancerMetastatic Renal Cell Cancer+1 more Ipsen 201
Not applicableWithdrawnNCT01781442What this trial is testingA Post Marketing Surveillance As Required By Philippine Food And Drug AdministrationWho this might be right forRenal Cell Carcinoma Pfizer
Large-scale testing (Phase 3)Study completedNCT00732914What this trial is testingSequential Study to Treat Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Sponsor GmbH 272